CMRX Chimerix 8-K2021Chimerix Acquires Oncoceutics to Expand Pipeline with Late-Stage Oncology Program
13 Jan 21
Files
SEC
Content Analysis
?
| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
|
|
CMRX 8-K Filings
- 21 Jan 21 Chimerix Announces Proposed $75,000,000 Public Offering of Common Stock
- 13 Jan 21 Chimerix Acquires Oncoceutics to Expand Pipeline with Late-Stage Oncology Program
- 8 Jan 21 Acquisition of Oncoceutics Adds Precision Oncology Pipeline with Near - term Registration Potential
- 23 Dec 20 Entry into a Material Definitive Agreement
- 5 Nov 20 Chimerix Reports Third Quarter 2020 Financial Results and Provides Operational Update
Filing View
Search this filing
Table of Contents
Get all this for free
- Email alerts for new filings that match keywords or companies
- Plot, compare & download financial data
- 10-K & 10-Q redlined comparisons
- Advanced filing search & analysis
- Sentiment analysis for financial filings
- Favorites, search history, and more…